As a world leader in modern visual electrophysiology, Diopsys, Inc. has advanced the use of electroretinography (ERG) and visual evoked potential (VEP) in the eye care practice. The company’s unique, patented technology provides eye care professionals with objective, functional information about the health of the vision system to aid in the early detection of vision disorders, and post-treatment tracking for enhanced patient management.
Diopsys offers a full suite of visual electrophysiology modules, including PERG, ffERG, and VEP. Diopsys® ERG and VEP vision tests can be performed on the Diopsys® NOVA™ (cart) or Diopsys® ARGOS™ (tabletop) system.
The company understands the important role of early medical intervention for correctable vision problems, which can lead to an improved quality of life. Early detection means better patient outcomes.
Contact Diopsys via;
- < Previous story Award goes to NIDEK
- Next story A milling technology available to small labs and retail optical shops >